121. Reverting to the response provided by the delegation of the European Union, the representative of India clarified that he was trying to relate the situation in Greece to that in developing countries. Difficulties in accessing medicines caused by the IP system were normal for them, but the example of Greece showed that even a developed country could face access problems because of IP. If Greece had an option to import generic medicines from another manufacturer, it could solve the problem.
